Worldwide Cardiac Prosthetic Devices Industry to 2025 - by Product Type, End-user and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cardiac Prosthetic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global cardiac prosthetic devices market is currently witnessing a healthy growth. Looking forward, the publisher expects the market to grow at a CAGR of around 8% during 2020-2025.

Cardiac prosthetic devices refer to artificial devices that are implanted permanently or temporarily for repairing and replacing damaged heart tissues. Prosthetic heart valves, ventricular assist devices, pacemakers and annuloplasty rings are some of the commonly used cardiac prosthetic devices.

Heart valves, including mechanical, tissue (stented/stent-less) and transcatheter valves, are used to prevent retrograde blood flow and leakages. On the other hand, pacemakers are used for maintaining a stable heart rate using electrical impulses. These devices are configured to mimic the normal functioning of cardiovascular organs, and they also aid in preventing further blockages in the heart valves.

Owing to the sedentary lifestyles led by a majority of the population, coupled with their unhealthy dietary habits, there is an increasing prevalence of cardiovascular diseases (CVDs) and various heart ailments, such as cardiomyopathy and Coronary Artery Disease (CAD) across various regions. In line with this, the rising number of individuals with Marfan syndrome, which affects the heart and lungs, along with other vital organs in the body, is also contributing to the market growth. People with this inherited disease of connective tissues endure a damaged aorta and mitral valve prolapse, which may eventually require cardiac prosthetic device implantation as a treatment option for the effective working of the heart.

Furthermore, various technological advancements, such as the development of compact pacemakers and suture-less valve replacements, are acting as another growth-inducing factor. These devices are manufactured using durable and biocompatible raw materials and can be implanted into the patient's body through minimally invasive (MI) procedures. Other factors, including the growing geriatric population, improving healthcare infrastructure, rising awareness regarding the available treatment for CVDs and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.

Companies Mentioned

• Abbott Laboratories
• Biotronik
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Lepu Medical Technology Co. Ltd.
• Medtronic Inc.
• Meril Life Sciences Pvt. Ltd.
• Siemens Healthcare GmbH
• Sorin Group
• St. Jude Medical Inc.
  

Key Questions Answered in this Report:

• How has the global cardiac prosthetic devices market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What is the breakup of the market based on the product type?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global cardiac prosthetic devices market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Cardiac Prosthetic Devices Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Product Type

6.1 Valves

6.2 Pacemakers

6.3 Implantable Pacemakers

6.4 External Pacemakers

6.5 Others

7 Market Breakup by End-User

7.1 Hospitals, Clinics and Cardiac Centers

7.2 Ambulatory Surgical Centers

7.3 Others

8 Market Breakup by Region

8.1 North America

8.2 Asia Pacific

8.3 Europe

8.4 Latin America

8.5 Middle East and Africa

9 SWOT Analysis

9.1 Overview

9.2 Strengths

9.3 Weaknesses

9.4 Opportunities

9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview

11.2 Bargaining Power of Buyers

11.3 Bargaining Power of Suppliers

11.4 Degree of Competition

11.5 Threat of New Entrants

11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure

13.2 Key Players

13.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/djvec3